PAncreatic Disease Cohort of TOuLouse
Recruiting · NCT05824403 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Toulouse
View the official record on ClinicalTrials.gov →What this trial is about
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with inflammatory or cystic exocrine pancreatic pathology
- Patient able to read and understand the information leaflet
- Patients who have agreed to participate in the study and have signed the free and informed consent
- Patients affiliated to a social security system (including AME)
Exclusion criteria
- Patient with pancreatic cancer pathology
- Patients with active cancer, whatever the origin
- Pregnant or breastfeeding patients
- Patients under legal protection, guardianship or trusteeship
Where it is running
1 location listed.
- Rangueil hospital - Toulouse, France